Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: belimumab

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP  |  July 1, 2014

An update on baricitinib, plus safety warnings on belimumab,
eszopiclone and zoledronic acid

Filed under:Biologics/DMARDsConditionsDrug UpdatesResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:ActemrabaricitinibbelimumabBiologicsdrugLupusResearchRheumatoid arthritisSafetySystemic lupus erythematosustocilizumabzoledronic acid

The 2014 ACR/ARHP Annual Meeting Offers Programs for Rheumatology Clinicians, Researchers, Practice Management Professionals

Staff  |  July 1, 2014

Rheumatology’s premier event to be held in Boston from Nov. 14–19

Filed under:Billing/CodingBiologics/DMARDsCareer DevelopmentConditionsDrug UpdatesEducation & TrainingFrom the CollegePractice SupportProfessional TopicsQuality Assurance/ImprovementSystemic Lupus Erythematosus Tagged with:AC&RACR/ARHP Annual Meetingalternative therapiesAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)BillingBiologicsCodingdrugLupusmacrophage activation syndromePractice ManagementrheumatologistSystemic lupus erythematosus

Childhood-onset Lupus Brings Distinct Challenges at Each Phase of Life

Deborah M. Levy, MD, MS  |  January 1, 2014

Differences in disease manifestations, severity, and management require special consideration from rheumatologists who treat children and adolescents with systemic lupus erythematosus

Filed under:ConditionsPediatric ConditionsSystemic Lupus Erythematosus Tagged with:drugHYDROXYCHLOROQUINELupusMethotrexatepatient carePediatricPediatricsprednisonerheumatologistrituximabSLESystemic lupus erythematosusTreatment

ACR Winter Rheumatology Symposium: The Search for Answers in Sjögren’s Syndrome

Kimberly Retzlaff  |  May 1, 2013

Research has led to greater understanding of the disease, potential for better treatment options

Filed under:ConditionsMeeting ReportsResearch RheumSjögren’s Disease Tagged with:ACR Winter Rheumatology SymposiumResearchSjogren'sTreatment

California Rheumatologists Explore Managed Care, Treatment Options

Larry Beresford  |  July 9, 2012

Advances in SLE, osteoporosis, and RA highlighted at California Rheumatology Alliance meeting.

Filed under:Career DevelopmentConditionsEducation & TrainingLegislation & AdvocacyOsteoarthritis and Bone DisordersProfessional TopicsResearch Rheum Tagged with:ACAAffordable Care Act (ACA)BiologicsdrugHealthcare ReformLegislationLupusmanaged careMedicareOsteoporosispatient careradiographResearchRheumatoid arthritisrheumatologistSystemic lupus erythematosus

The State-of-the-Art of Rheumatology Symposium

Lara C. Pullen, PhD  |  June 10, 2012

Experts from across the nation describe the best clinical approaches to rheumatologic disease management.

Filed under:ConditionsGout and Crystalline ArthritisResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:AC&RAmerican College of Rheumatology (ACR)anti-inflammatoryColchicineGoutHYDROXYCHLOROQUINELupuspatient carepregnancyResearchRheumatoid arthritisrheumatologistSystemic lupus erythematosus

The American College of Rheumatology (ACR) can Help Combat Insurance Frustrations

James R. O’Dell, MD  |  April 6, 2012

When it comes to dealing with insurance companies, the rules seem to change frequently and always in an arbitrary and capricious way. The ACR is trying its best to protect rheumatologists, but we need your help!

Filed under:InsuranceLegislation & AdvocacyPractice SupportPresident's PerspectiveProfessional TopicsQuality Assurance/Improvement Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)druginsuranceLegislationLupusRheumatoid arthritisSystemic lupus erythematosus

Clinical Trials Go Global

Sue Pondrom  |  November 1, 2011

As medical research expands to the global population, will trial results sill apply to U.S. populations?

Filed under:Drug Updates Tagged with:Approvalsclinical trialsDrugsFDAInternational

Strike While the Iron Is Hot

David Borenstein, MD  |  October 7, 2011

How The ACR Lupus Initiative is advancing rheumatology

Filed under:Education & TrainingPresident's Perspective Tagged with:AC&REducationLupusLupus Initiative

T Cells in Systemic Lupus Erythematosus

Mindy S. Lo, MD, PhD, and George C. Tsokos, MD  |  August 1, 2011

Progress toward targeted therapy

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:PathogenesisSystemic lupus erythematosusT-cellsTreatment

  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences